JP2020502121A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502121A5 JP2020502121A5 JP2019531750A JP2019531750A JP2020502121A5 JP 2020502121 A5 JP2020502121 A5 JP 2020502121A5 JP 2019531750 A JP2019531750 A JP 2019531750A JP 2019531750 A JP2019531750 A JP 2019531750A JP 2020502121 A5 JP2020502121 A5 JP 2020502121A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- vasodilator
- particles
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022197348A JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2025019782A JP2025065408A (ja) | 2016-12-14 | 2025-02-10 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662434185P | 2016-12-14 | 2016-12-14 | |
| US62/434,185 | 2016-12-14 | ||
| PCT/US2017/066519 WO2018112258A1 (en) | 2016-12-14 | 2017-12-14 | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197348A Division JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502121A JP2020502121A (ja) | 2020-01-23 |
| JP2020502121A5 true JP2020502121A5 (https=) | 2021-01-28 |
Family
ID=60888760
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019531750A Pending JP2020502121A (ja) | 2016-12-14 | 2017-12-14 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2022197348A Pending JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2025019782A Pending JP2025065408A (ja) | 2016-12-14 | 2025-02-10 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022197348A Pending JP2023036678A (ja) | 2016-12-14 | 2022-12-09 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
| JP2025019782A Pending JP2025065408A (ja) | 2016-12-14 | 2025-02-10 | 肺高血圧症および他の肺障害の処置のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US10912778B2 (https=) |
| EP (2) | EP4620525A3 (https=) |
| JP (3) | JP2020502121A (https=) |
| CN (1) | CN110381951A (https=) |
| AU (3) | AU2017378409A1 (https=) |
| BR (1) | BR112019012251A2 (https=) |
| CA (1) | CA3046025A1 (https=) |
| MX (1) | MX2019006938A (https=) |
| RU (1) | RU2019121646A (https=) |
| WO (1) | WO2018112258A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2938343B1 (en) | 2012-12-21 | 2018-09-12 | Mayo Foundation For Medical Education And Research | Methods and materials for treating calcific aortic valve stenosis |
| US10898494B2 (en) | 2016-05-05 | 2021-01-26 | Liquidia Technologies, Inc. | Dry powder treprostinil for the treatment of pulmonary hypertension |
| EP4620525A3 (en) | 2016-12-14 | 2025-12-03 | Respira Therapeutics, Inc. | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
| WO2018132371A2 (en) * | 2017-01-10 | 2018-07-19 | United Therapeutics Corporation | Methods and compositions for treating pulmonary hypertension |
| WO2020210707A1 (en) * | 2019-04-10 | 2020-10-15 | Mayo Foundation For Medical Education And Research | Methods and materials for gender-dependent treatment of cardiovascular dysfunction |
| KR20220019027A (ko) * | 2019-06-10 | 2022-02-15 | 레스피라 테라퓨틱스 인크. | 담체-기반 제제 및 관련 방법 |
| CN112569210B (zh) * | 2019-09-27 | 2023-09-15 | 盈科瑞（天津）创新医药研究有限公司 | 一种吸入用马昔腾坦溶液及其制备方法 |
| CN112773898A (zh) * | 2019-11-11 | 2021-05-11 | 广州华真医药科技有限公司 | 磷酸二酯酶5抑制剂在制备抗纤维化疾病药物中的应用 |
| CN110946826B (zh) * | 2019-12-12 | 2022-02-22 | 烟台大学 | 一种利奥西呱口服制剂及其制备方法 |
| JP7727652B2 (ja) | 2020-03-31 | 2025-08-21 | インヴォックス ベルジアム エヌヴイ | 少なくとも２つの液体組成物のエアロゾル送達 |
| US11013688B1 (en) * | 2020-05-28 | 2021-05-25 | Softhale Nv | Methods of treatment of viral diseases |
| KR20230096998A (ko) * | 2020-10-28 | 2023-06-30 | 인스메드 인코포레이티드 | 트레프로스티닐 전구약물의 건조 분말 조성물 및 이의 사용 방법 |
| US20250000873A1 (en) | 2021-09-10 | 2025-01-02 | Justus-Liebig-Universitaet Giessen | Inhaled iloprost for rescue treatment and treatment as needed in pulmonary hypertension |
| CN121843699A (zh) * | 2023-05-31 | 2026-04-10 | 瑞必治公司 | 肺动脉高压治疗方法 |
| CN116687888A (zh) * | 2023-06-02 | 2023-09-05 | 苏州易合医药有限公司 | 伐地那非和达泊西汀复方干粉吸入制剂及其制备方法 |
| CN121714543A (zh) * | 2024-09-23 | 2026-03-24 | 上海欣药智能科技有限公司 | 一种可吸入的含可溶性鸟苷酸环化酶受体激动剂的药物组合物及其用途 |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1338235A (en) | 1970-12-15 | 1973-11-21 | May & Baker Ltd | Azapurinones |
| GB1493685A (en) | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
| US4883810A (en) | 1976-08-17 | 1989-11-28 | Burroughs Wellcome Co. | Ethers |
| US4306075A (en) | 1980-03-28 | 1981-12-15 | The Upjohn Company | Composition and process |
| JPS58124778A (ja) | 1982-01-20 | 1983-07-25 | Toray Ind Inc | ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体 |
| DE3417638A1 (de) | 1984-05-10 | 1985-11-14 | Schering AG, 1000 Berlin und 4709 Bergkamen | Verfahren zur bestimmung geringer stoffmengen von arzneimitteln, von koerpereigenen oder anderen chemischen substanzen in biologischem material |
| US5250534A (en) | 1990-06-20 | 1993-10-05 | Pfizer Inc. | Pyrazolopyrimidinone antianginal agents |
| GB9401090D0 (en) | 1994-01-21 | 1994-03-16 | Glaxo Lab Sa | Chemical compounds |
| GB9514464D0 (en) | 1995-07-14 | 1995-09-13 | Glaxo Lab Sa | Medicaments |
| US6565885B1 (en) | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
| US6441245B1 (en) | 1997-10-24 | 2002-08-27 | United Therapeutics Corporation | Process for stereoselective synthesis of prostacyclin derivatives |
| US6362178B1 (en) | 1997-11-12 | 2002-03-26 | Bayer Aktiengesellschaft | 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
| US6521212B1 (en) | 1999-03-18 | 2003-02-18 | United Therapeutics Corporation | Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation |
| US6943166B1 (en) | 1999-04-30 | 2005-09-13 | Lilly Icos Llc. | Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction |
| EA004872B1 (ru) | 1999-08-03 | 2004-08-26 | ЛИЛЛИ АЙКОС эЛ-эЛ-Си | β-КАРБОЛИНОВЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ |
| US6821975B1 (en) | 1999-08-03 | 2004-11-23 | Lilly Icos Llc | Beta-carboline drug products |
| EP1219609B1 (en) | 1999-09-16 | 2007-04-04 | Tanabe Seiyaku Co., Ltd. | Aromatic nitrogenous six-membered ring compounds |
| NZ524572A (en) | 2000-09-06 | 2004-08-27 | Tanabe Seiyaku Co | Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions |
| WO2002079143A1 (en) | 2001-03-28 | 2002-10-10 | Pfizer Limited | N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| TWI316055B (https=) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
| US20040077624A1 (en) | 2002-05-23 | 2004-04-22 | Pfizer Inc. | Novel combination |
| CA2536293A1 (en) * | 2003-08-22 | 2005-03-03 | Boehringer Ingelheim Pharmaceuticals, Inc. | Methods of treating copd and pulmonary hypertension |
| JP2008546786A (ja) | 2005-06-23 | 2008-12-25 | シェーリング コーポレイション | Ｐｄｅ５インヒビターの迅速吸収性経口処方物 |
| CA2641393C (en) | 2006-02-03 | 2014-12-16 | Scidose Llc | Novel epoprostenol formulation and method of making thereof |
| CN101495122B (zh) | 2006-05-15 | 2011-10-05 | 联合治疗公司 | 使用定量吸入器给予曲前列尼 |
| KR20160048222A (ko) | 2007-12-17 | 2016-05-03 | 유나이티드 세러퓨틱스 코오포레이션 | 레모둘린?의 활성 성분인 트레프로스티닐의 개선된 제조 방법 |
| WO2009086470A2 (en) | 2007-12-27 | 2009-07-09 | Aires Pharmaceuticals, Inc. | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof |
| KR20230085944A (ko) | 2008-03-18 | 2023-06-14 | 아레나 파마슈티칼스, 인크. | 프로스타시클린 （ｐｇｉ２） 수용체와 관련된 장애의 치료에 유용한 상기 수용체의 조절제 |
| WO2009115235A1 (en) | 2008-03-20 | 2009-09-24 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of pulmonary hypertension |
| LT2315587T (lt) | 2008-08-13 | 2018-01-10 | Actelion Pharmaceuticals Ltd. | Terapinės kompozicijos, turinčios macitentano |
| KR20170024165A (ko) | 2009-06-26 | 2017-03-06 | 니뽄 신야쿠 가부시키가이샤 | 결정 |
| WO2011030351A2 (en) | 2009-09-03 | 2011-03-17 | Rubicon Research Private Limited | Taste - masked pharmaceutical compositions |
| EP2480526A1 (en) | 2009-09-23 | 2012-08-01 | Arena Pharmaceuticals, Inc. | Crystalline forms and processes for the preparation of pgi2 receptor agonists |
| EP3108888B1 (en) * | 2010-03-15 | 2020-02-12 | United Therapeutics Corporation | Treatment for pulmonary hypertension |
| WO2011137734A1 (en) | 2010-05-03 | 2011-11-10 | Tsh Biopharm Company, Limited | Pharmaceutical composition and method for treating hypertension |
| EP2593452B1 (en) | 2010-07-14 | 2017-01-18 | Novartis AG | Ip receptor agonist heterocyclic compounds |
| EP2464346A1 (en) | 2010-08-30 | 2012-06-20 | Pulmatrix, Inc. | Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder |
| US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
| US10463815B2 (en) | 2012-02-21 | 2019-11-05 | Respira Therapeutics, Inc. | Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents |
| CN104853744B (zh) | 2012-10-31 | 2018-01-19 | 维克多瑞有限责任公司 | 气溶胶化伊洛前列素的给药 |
| US20160317542A1 (en) | 2013-12-09 | 2016-11-03 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
| EP3110484A4 (en) | 2014-02-21 | 2018-02-14 | Respira Therapeutics, Inc. | Powder inhaler, system and methods |
| EP3244968B1 (en) * | 2015-01-13 | 2023-08-30 | Vivus LLC | Combination therapy for pulmonary hypertension |
| EP4620525A3 (en) | 2016-12-14 | 2025-12-03 | Respira Therapeutics, Inc. | Methods and compositions for treatment of pulmonary hypertension and other lung disorders |
-
2017
- 2017-12-14 EP EP25178206.6A patent/EP4620525A3/en active Pending
- 2017-12-14 WO PCT/US2017/066519 patent/WO2018112258A1/en not_active Ceased
- 2017-12-14 MX MX2019006938A patent/MX2019006938A/es unknown
- 2017-12-14 US US16/469,524 patent/US10912778B2/en active Active
- 2017-12-14 BR BR112019012251-6A patent/BR112019012251A2/pt unknown
- 2017-12-14 EP EP17823002.5A patent/EP3554507A1/en not_active Ceased
- 2017-12-14 CN CN201780086527.2A patent/CN110381951A/zh active Pending
- 2017-12-14 JP JP2019531750A patent/JP2020502121A/ja active Pending
- 2017-12-14 AU AU2017378409A patent/AU2017378409A1/en not_active Abandoned
- 2017-12-14 CA CA3046025A patent/CA3046025A1/en active Pending
- 2017-12-14 RU RU2019121646A patent/RU2019121646A/ru unknown
-
2021
- 2021-01-11 US US17/146,173 patent/US11491160B2/en active Active
- 2021-11-23 US US17/534,282 patent/US11491161B2/en active Active
-
2022
- 2022-06-29 US US17/853,005 patent/US12263174B2/en active Active
- 2022-10-17 AU AU2022256085A patent/AU2022256085A1/en not_active Abandoned
- 2022-12-09 JP JP2022197348A patent/JP2023036678A/ja active Pending
-
2025
- 2025-02-10 JP JP2025019782A patent/JP2025065408A/ja active Pending
- 2025-02-26 US US19/064,180 patent/US20250195531A1/en active Pending
- 2025-11-03 AU AU2025260006A patent/AU2025260006A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502121A5 (https=) | ||
| RU2019121646A (ru) | Способы и композиции для лечения легочной гипертензии и других заболеваний легких | |
| JP6669808B2 (ja) | 超低密度肺粉剤 | |
| US6921528B2 (en) | Highly efficient delivery of a large therapeutic mass aerosol | |
| JP2023036678A5 (https=) | ||
| JP7277490B2 (ja) | 肺送達用ラパマイシン粉末 | |
| TW200938232A (en) | Novel dosage and formulation | |
| JP2016519160A (ja) | ３つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム | |
| HK1200343A1 (en) | An inhalable medicament comprising tiotropium | |
| TW202342035A (zh) | 醫藥乾粉吸入配製物 | |
| ES2371601T3 (es) | Composición para inhalación. | |
| JPWO2020055824A5 (https=) | ||
| EP2821061B1 (en) | Novel inhalation formulations | |
| EP2957553A1 (en) | Pharmaceutical formulations of vilanterol | |
| EP2957552B1 (en) | Vilanterol formulations | |
| EP4472609A1 (en) | Inhaled imatinib for treatment of pulmonary hypertension | |
| CN116600790A (zh) | 治疗肺纤维化的方法和组合物 | |
| EP2957551B1 (en) | Dry powder formulations comprising vilanterol | |
| JP2017530988A (ja) | チオトロピウム、アミノ酸及び酸を含有する製剤、並びにその方法 | |
| JP2021532098A5 (https=) | ||
| KR20250169548A (ko) | 분무 건조 트레프로스티닐 제형 | |
| Son et al. | Optimizing Spray-Dried Porous Particles for High Dose Delivery with a Portable Dry Powder Inhaler. Pharmaceutics 2021, 13, 1528 | |
| CN121714543A (zh) | 一种可吸入的含可溶性鸟苷酸环化酶受体激动剂的药物组合物及其用途 | |
| EP2957550A1 (en) | Pharmaceutical formulations comprising vilanterol | |
| JP2013177429A (ja) | 吸入組成物 |